🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Enanta Pharmaceuticals, Inc. (ENTA)
NASDAQ: ENTA · Real-Time Price · USD
8.23
-0.46 (-5.29%)
Nov 18, 2026, 4:00 PM EST - Market closed

Enanta Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Oct - Sep.

Assets

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Cash & Equivalents
20.2732.337.2385.3943.99
Short-Term Investments
174.24156.57210.95284.52205.24
Cash & Short-Term Investments
194.51188.86248.19369.91249.23
Cash Growth
2.99%-23.90%-32.91%48.42%2.14%
Accounts Receivable
5.866.886.658.6120.32
Other Receivables
--323128.72
Receivables
5.866.8838.6539.6249.04
Prepaid Expenses
5.638.5912.4113.2613.45
Restricted Cash
--0.61--
Total Current Assets
205.99204.34299.85422.79311.71
Property, Plant & Equipment
66.1172.9473.3534.7129.75
Long-Term Investments
----29.29
Other Long-Term Assets
3.483.453.454.774.66
Total Assets
275.58280.73376.65462.28375.41

Liabilities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Accounts Payable
2.751.9584.16
Accrued Expenses
14.6912.7513.5518.3420.94
Current Portion of Long-Term Debt
32.9730.7134.4635.08-
Current Portion of Leases
4.063.151.525.282.89
Total Current Liabilities
54.4648.5657.5462.7929.83
Long-Term Debt
89.93112.44136.13160.851.42
Long-Term Leases
50.754.7653.9421.2422.37
Other Long-Term Liabilities
0.30.260.230.660.45
Total Liabilities
195.38216.02247.84245.5454.08

Shareholders' Equity

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Common Stock
80.20.210.210.210.21
Additional Paid-In Capital
-469.77451.34424.69398.03
Retained Earnings
--404.93-323.04-207-73.18
Comprehensive Income & Other
--0.340.3-1.17-3.72
Shareholders' Equity
80.264.72128.81216.74321.33
Total Liabilities & Equity
275.58280.73376.65462.28375.41

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Sep '25 Sep '24 Sep '23 Sep '22
Total Debt
177.65201.06226.06222.4426.69
Net Cash (Debt)
16.86-12.1922.13147.47251.83
Net Cash Growth
---85.00%-41.44%-27.13%
Net Cash Per Share
0.58-0.571.057.0312.22
Filing Date Shares Outstanding
29.1328.8621.1921.0620.8
Total Common Shares Outstanding
29.1321.3921.1921.0620.79
Working Capital
151.53155.78242.32360281.89
Book Value Per Share
2.753.036.0810.2915.46
Tangible Book Value
80.264.72128.81216.74321.33
Tangible Book Value Per Share
2.753.036.0810.2915.46
Machinery
-20.3919.9219.1416.79
Construction In Progress
--22.751.272.56
Leasehold Improvements
-38.213.9813.87.28
SEC Filings: 10-K · 10-Q